Sercloremine
From Wikipedia, the free encyclopedia
Sercloremine | |
---|---|
IUPAC name 4-(5-Chloro-1-benzofuran-2-yl)-1-methylpiperidine | |
Identifiers | |
CAS number | 54403-19-9 |
PubChem | 162749 |
ChemSpider | 142884 |
Jmol-3D images | Image 1 |
| |
| |
Properties | |
Molecular formula | C14H16ClNO |
Molar mass | 249.74 g mol−1 |
Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa) | |
Infobox references | |
Sercloremine, usually as a hydrochloride, is an experimental drug candidate under study as an antidepressant.[1] This drug was developed by Novartis and is in Phase II clinical trials.[2]
References
- ↑ US Patent 4600719 - Tetrahydropyridine and piperidine derivatives
- ↑ "Chemdrug data page" (in Chinese, and English). Chemdrug. Retrieved July 29, 2011.
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.